NIT
AMRI

NumerixS Investment Technologies’s Albany Molecular Research Inc AMRI Stock Holding History

NumerixS Investment Technologies’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,900
Closed -$197K – 1311
2016
Q1 		$197K Buy
+12,900
New +$202K 0.02% 765

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

NumerixS Investment Technologies's AMRI Position: Q2 2016 in Review

NumerixS Investment Technologies sold out of Albany Molecular Research Inc (AMRI) in Q2 2016, closing a stake of 12,900 shares — an estimated $197K sold.

NumerixS Investment Technologies first reported a position in AMRI in Q1 2016 and held it in 1 quarter. The position peaked at $197K in Q1 2016. 142 funds tracked by Wall St. Rank hold AMRI as of Q2 2016.

  • NumerixS Investment Technologies reported no remaining Albany Molecular Research Inc position as of Q2 2016 after selling out during the quarter.
  • NumerixS Investment Technologies sold 12,900 Albany Molecular Research Inc shares in Q2 2016, an estimated $197K.
  • NumerixS Investment Technologies first reported a position in Albany Molecular Research Inc in Q1 2016 and held it in 1 quarter.
  • NumerixS Investment Technologies's Albany Molecular Research Inc position peaked at $197K in Q1 2016.
  • 142 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2016.

Based on NumerixS Investment Technologies's 13F filing for Q2 2016, filed 11 Aug 2016.